We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

The Promise and Limits of Cancer Immunotherapy

Video   Mar 27, 2019 | Taken from TEDMED, YouTube

 

Since its advent, there have been numerous conflicting reports about whether immunotherapy will be a “silver bullet” for different types of cancer, or if such expectations are based on hype or limited evidence. Many of the misconceptions about immunotherapy’s potential are due to our limited understanding of the immune system and how it serves to protect us from disease.

A pioneer in cancer care treatment, oncologist Lennie Sender has a deep understanding of both the possibilities and limitations of harnessing the immune system to treat different types of cancer. Check out Lennie’s TEDMED Talk for his straightforward report of the state of cancer immunotherapy options today and the promise they may hold for the future.

 
More Information
 
 
 

Recommended Videos

Proximity Proteomics

Video

By joining forces and combining technologies in a new way, Harvard Medical School researchers have captured the first bird’s eye views of what happens at the molecular level when drugs, hormones and neurotransmitters activate certain kinds of cell receptors. Until now, scientists had been able to see only one part of the picture at a time.

WATCH NOW

Why Labs Are Printing the Coronavirus Genome

Video

The world is struggling to contain the new coronavirus outbreak. But thanks to new genetic material sequencing and synthesis technology, scientists are able to identify and study this virus quicker than ever before. Will it be enough?

WATCH NOW

The Accident That Changed the World

Video

Learn how Alexander Fleming discovered penicillin, and how the antibiotic has changed medicine and the treatment of infections.

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Biopharma Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE